In the larger-sample-size TCGA cohort, it also showed a higher mutation frequency of APC and PCBP1 in KRAS-Mut samples than in WT tumor samples (adjusted chi-square test, P < 0.05; Figure S5A). This evidence concerns the gene KRAS and neoplasm.